TriSalus Life Sciences - CW | 8-K: FY2025 Q4 Revenue: USD 13.2 M
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2025 Q4, the actual value is USD 13.2 M.
Financial Metrics by Segment
Segment Revenue
- Fourth Quarter 2025 Revenue: Approximately $13.2 million, up 60% year-over-year from $8.3 million in the prior year and a sequential quarterly growth of approximately 14%.
- Full-Year 2025 Revenue: Approximately $45.2 million, up 53% year-over-year from $29.4 million in the prior year.
Operational Metrics
- Year-End Cash and Cash Equivalents: Approximately $20.4 million as of December 31, 2025, compared to $22.7 million at the start of the fourth quarter, reflecting a reduction of $2.3 million.
Outlook / Guidance
- 2026 Revenue Guidance: The company expects full-year 2026 revenues to be in the range of approximately $60 million to $62 million.
